pifithrin has been researched along with Obesity in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Homayounfar, R | 1 |
| Jeddi-Tehrani, M | 1 |
| Cheraghpour, M | 1 |
| Ghorbani, A | 1 |
| Zand, H | 1 |
1 other study available for pifithrin and Obesity
| Article | Year |
|---|---|
Relationship of p53 accumulation in peripheral tissues of high-fat diet-induced obese rats with decrease in metabolic and oncogenic signaling of insulin.
Topics: Adipose Tissue; Adiposity; Animals; Benzothiazoles; Body Weight; Diet, High-Fat; Fluorescent Antibod | 2015 |